The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 12 2020
revised: 30 03 2021
accepted: 31 03 2021
pubmed: 28 5 2021
medline: 14 7 2021
entrez: 27 5 2021
Statut: ppublish

Résumé

Lynch syndrome (LS) is a hereditary cancer syndrome that accounts for 3% of all new colorectal cancer (CRC) cases. Patients carry a germline pathogenic variant in one of the mismatch repair (MMR) genes (MLH1, MSH2, MSH6 or PMS2), which encode proteins involved in a post-replicative proofreading and editing mechanism. The clinical presentation of LS is highly heterogeneous, showing high variability in age at onset and penetrance of cancer, which may be partly attributable to the molecular profiles of carcinomas. This review discusses the frequency of alterations in the WNT/B-CATENIN, RAF/MEK/ERK and PI3K/PTEN/AKT pathways identified in all four LS subgroups and how these changes may relate to the 'three pathway model' of carcinogenesis, in which LS CRCs develop from MMR-proficient adenomas, MMR-deficient adenomas or directly from MMR-deficient crypts. Understanding the specific differences in carcinogenesis for each LS subgroup will aid in the further optimization of guidelines for diagnosis, surveillance and treatment.

Identifiants

pubmed: 34044097
pii: S1040-8428(21)00126-8
doi: 10.1016/j.critrevonc.2021.103338
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103338

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Noah C Helderman (NC)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.

Sanne W Bajwa-Ten Broeke (SW)

Department of Clinical Genetics, UMC Groningen, the Netherlands.

Hans Morreau (H)

Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.

Manon Suerink (M)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.

Diantha Terlouw (D)

Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.

Anne-Sophie van der Werf-' T Lam (AS)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.

Tom van Wezel (T)

Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.

Maartje Nielsen (M)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: m.nielsen@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH